Do not think for the purposes of the first 12 months, where the FDA itself is going slow on critical internal process and we have the pandemic, that they do not have a clear and straightforward pathway to extending that as needed.
I do believe that they likely will have what they need soon to go forward, if they do not think they have it now.
Market Data 
Markets 
AI
